Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Plos One
|
July 28, 2025
Hyperparameter tuned deep learning-driven medical image analysis for intracranial hemorrhage detection
Naif Almakayeel, E Laxmi Lydia, Oleg Razzhivin, et al.
Bioorganic Chemistry
|
February 9, 2018
Ionic liquid-enabled synthesis, cholinesterase inhibitory activity, and molecular docking study of highly functionalized tetrasubstituted pyrrolidines
Raju Suresh Kumar, Abdulrahman I Almansour, Natarajan Arumugam, et al.
The Journal of Biological Chemistry
|
March 25, 2010
NuA4-dependent acetylation of nucleosomal histones H4 and H2A directly stimulates incorporation of H2A.Z by the SWR1 complex
Mohammed Altaf, Andréanne Auger, Julie Monnet-Saksouk, et al.
Clinical & Translational Immunology
|
December 14, 2020
Rapid detection of SARS-CoV-2-specific memory T-cell immunity in recovered COVID-19 cases
Katie E Lineburg, Sriganesh Srihari, Mohammed Altaf, et al.
Omics : a Journal of Integrative Biology
|
February 16, 2019
Proteomics and Visual Health Research: Proteome of the Human Sclera Using High-Resolution Mass Spectrometry
Varshasnata Mohanty, Yashwanth Subbannayya, Mohammed Altaf Najar, et al.
The Journal of Infectious Diseases
|
December 4, 2020
Pretransplant Cytomegalovirus-Specific Cellular Immunity and Risk of Viral Reactivation Following Lung Transplantation: A Prospective Cohort Study
Mohammed Altaf, Katie E Lineburg, Pauline Crooks, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 12, 2026
T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy
Mohammed Altaf, Carla Nel, Timothy Tipoe, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 12, 2026
Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO Trial
Ming Jie Lee, Louise-Rae Cherrill, Panagiota Zacharopoulou, et al.
The Lancet. HIV
|
May 27, 2026
Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial
Ming J Lee, Louise-Rae Cherrill, Panagiota Zacharopoulou, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Plos One
|
July 28, 2025
Hyperparameter tuned deep learning-driven medical image analysis for intracranial hemorrhage detection
Naif Almakayeel, E Laxmi Lydia, Oleg Razzhivin, et al.
Bioorganic Chemistry
|
February 9, 2018
Ionic liquid-enabled synthesis, cholinesterase inhibitory activity, and molecular docking study of highly functionalized tetrasubstituted pyrrolidines
Raju Suresh Kumar, Abdulrahman I Almansour, Natarajan Arumugam, et al.
The Journal of Biological Chemistry
|
March 25, 2010
NuA4-dependent acetylation of nucleosomal histones H4 and H2A directly stimulates incorporation of H2A.Z by the SWR1 complex
Mohammed Altaf, Andréanne Auger, Julie Monnet-Saksouk, et al.
Clinical & Translational Immunology
|
December 14, 2020
Rapid detection of SARS-CoV-2-specific memory T-cell immunity in recovered COVID-19 cases
Katie E Lineburg, Sriganesh Srihari, Mohammed Altaf, et al.
Omics : a Journal of Integrative Biology
|
February 16, 2019
Proteomics and Visual Health Research: Proteome of the Human Sclera Using High-Resolution Mass Spectrometry
Varshasnata Mohanty, Yashwanth Subbannayya, Mohammed Altaf Najar, et al.
The Journal of Infectious Diseases
|
December 4, 2020
Pretransplant Cytomegalovirus-Specific Cellular Immunity and Risk of Viral Reactivation Following Lung Transplantation: A Prospective Cohort Study
Mohammed Altaf, Katie E Lineburg, Pauline Crooks, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 12, 2026
T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy
Mohammed Altaf, Carla Nel, Timothy Tipoe, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 12, 2026
Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO Trial
Ming Jie Lee, Louise-Rae Cherrill, Panagiota Zacharopoulou, et al.
The Lancet. HIV
|
May 27, 2026
Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial
Ming J Lee, Louise-Rae Cherrill, Panagiota Zacharopoulou, et al.
Page
of 3